Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06752681
Title	To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Day One Biopharmaceuticals, Inc.
Indications	ovarian cancer lung small cell carcinoma triple-receptor negative breast cancer cervical squamous cell carcinoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma gastric adenocarcinoma endometrial cancer esophagus squamous cell carcinoma lung non-small cell carcinoma
Therapies	MTX-13
Age Groups:	adult \| senior
Covered Countries	USA